Athira Pharma, Inc.
ATHA
Revenue
0.00
0.000.00%
-Assets
111.25M
▼-22.21M▼-16.64%
3 Months ChangeLiabilities
27.92M
▲1.20M▲4.50%
3 Months ChangeFree Cash Flow
-25.81M
▲626.00k▲2.37%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0000950170-24-115592
2024-10-07
Form 8-K
ID: 0000950170-24-113210
2024-09-17
Form 8-K
ID: 0000950170-24-107031
2024-09-03
Form 8-K
ID: 0000950170-24-102788
2024-08-01
Form 10-Q
ID: 0000950170-24-089304
2024-08-01
Form 8-K
ID: 0000950170-24-089281
2024-05-29
Form 8-K
ID: 0000950170-24-065914
2024-05-17
Form 8-K
ID: 0000950170-24-061837
2024-05-15
Form 10-Q
ID: 0000950170-24-060482
2024-05-15
Form 8-K
ID: 0000950170-24-060452